NCT03862131 2025-07-29PROACTWashington University School of MedicinePhase 2 Terminated49 enrolled 12 charts
NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts
NCT00656305 2020-02-05ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of PainInSightecPhase NA Completed147 enrolled 12 charts
NCT00896454 2018-10-17Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumAmgenPhase 2 Completed33 enrolled 22 charts